Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
Quick Stats
Mar 30, 202657.4
AI Score
HOLD0.53
Volume Ratio
Feb 18, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
IMVT Stock Summary
Last updated Mar 30, 2026
IMVT is currently trading at $23.965, positioned above its 200-day moving average of $21.04, indicating a long-term uptrend. The stock has a 52-week range of $12.72 to $29.25.
Technical Analysis: The 50-day moving average stands at $25.87, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 42.659, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.076, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates IMVT at 57.4/100 with a HOLD recommendation.
IMVT (Immunovant, Inc. Common Stock) Indicators
Last updated Mar 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 42.659 |
| CMF (20) | -0.076 |
| ROC (10) | -3.84 |
| ADX (14) | 13.204 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.583 |
| AROONOSC (14) | -57.143 |
| WILLAMS %R (14) | -60.565 |
| MFI (14) | 34.734 |
IMVT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
IMVT Price vs Max Options Open Interest
IMVT Max Change In Options Open Interest
IMVT Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IMVT Daily Out of Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IMVT Daily In the Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IMVT Most Active Options by Volume(near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Immunovant, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
IMVT Moving Averages Analysis
Immunovant, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Mar 30, 2026
IMVT (Immunovant, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Mar 30, 2026
| Days | MA |
|---|---|
| 10 | 24.17 |
| 20 | 25.05 |
| 30 | 25.72 |
| 50 | 25.87 |
| 100 | 25.28 |
| 200 | 21.04 |
IMVT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 5.2 billion |
| Earnings/Share ($) | -2.67 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.5312 |
| EPS Estimate Next Year ($) | -2.6239 |
| WallStreet Target Price ($) | 40.3529 |
| Most Recent Quarter |